Diversity of metabolic profiles of cystic fibrosis pseudomonas aeruginosa during the early stages of lung infection

Microbiology (United Kingdom)

Volumn 161, Issue 7, 2015, Pages 1447-1462

  Jørgensen, Karin Meinike ^a   Wassermann, Tina ^b   Johansen, Helle Krogh ^b,c   Christiansen, Lasse Engbo ^d   Molin, Søren ^c,d   Høiby, Niels ^a,b   Ciofu, Oana ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c Technical University of Denmark   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 HYDROXYBENZOIC ACID; ACETIC ACID; ALANINE; ARABINITOL; ARGININE; ASPARTIC ACID; CARBOHYDRATE; CARBON; CITRIC ACID; FRUCTOSE; FUMARIC ACID; GLUTAMIC ACID; INOSINE; LEUCINE; MANNOSE; META TYRAMINE; N ACETYLGLUTAMIC ACID; NITROGEN; PHENETHYLAMINE; PROLINE; PYRUVIC ACID; QUININE SULFATE; SUCCINIC ACID;

AMINO ACID METABOLISM; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL METABOLISM; BACTERIUM ISOLATE; CARBOHYDRATE METABOLISM; CARBON METABOLISM; CATABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; CYSTIC FIBROSIS; LUNG; LUNG INFECTION; MICROARRAY ANALYSIS; NITROGEN METABOLISM; NONHUMAN; PARANASAL SINUS; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; COMPLICATION; DENMARK; HUMAN; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; METABOLISM; METABOLOME; MICROBIOLOGY; RESPIRATORY TRACT INFECTION;

PSEUDOMONAS AERUGINOSA;

CARBON; CYSTIC FIBROSIS; DENMARK; HUMANS; LONGITUDINAL STUDIES; LUNG; METABOLOME; NITROGEN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 84979797932     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.000093     Document Type: Article

References (78)

1. Aanaes, K., Rickelt, L. F., Johansen, H. K., von Buchwald, C., Pressler, T., Høiby, N. & Jensen, P. Ø. (2011). Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J Cyst Fibros 10, 114–120
2. Aanaes, K., Johansen, H. K., Poulsen, S. S., Pressler, T., Buchwald, C. & Høiby, N. (2013a). Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization. J Cyst Fibros 12, 81–87
3. Aanaes, K., von Buchwald, C., Hjuler, T., Skov, M., Alanin, M. & Johansen, H. K. (2013b). The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis. Am J Rhinol Allergy 27, e1–e4
4. Barth, A. L. & Pitt, T. L. (1995). Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol 33, 37–40
5. Barth, A. L. & Pitt, T. L. (1996). The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45, 110–119
6. Behrends, V., Ryall, B., Zlosnik, J. E. A., Speert, D. P., Bundy, J. G. & Williams, H. D. (2013). Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol 15, 398–408
7. Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M. & Høiby, N. (2009). Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44, 547–558
8. Bochner, B. R. (2009). Global phenotypic characterization of bacteria. FEMS Microbiol Rev 33, 191–205
9. Boulette, M. L., Baynham, P. J., Jorth, P. A., Kukavica-Ibrulj, I., Longoria, A., Barrera, K., Levesque, R. C. & Whiteley, M. (2009). Characterization of alanine catabolism in Pseudomonas aeruginosa and its importance for proliferation in vivo. J Bacteriol 191, 6329–6334
10. Brennan, A. L., Gyi, K. M., Wood, D. M., Johnson, J., Holliman, R., Baines, D. L., Philips, B. J., Geddes, D. M., Hodson, M. E. & Baker, E. H. (2007). Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 6, 101–109
11. Buchanan, P. J., Ernst, R. K., Elborn, J. S. & Schock, B. (2009). Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation. Biochem Soc Trans 37, 863–867
12. Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R. & other authors (2001). Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183, 444–452
13. Ciofu, O., Riis, B., Pressler, T., Poulsen, H. E. & Høiby, N. (2005). Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49, 2276–2282
14. Ciofu, O., Lee, B., Johannesson, M., Hermansen, N. O., Meyer, P., Høiby, N. & Scandinavian Cystic Fibrosis Study Consortium (2008). Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro nonmucoid revertants. Microbiology 154, 103–113
15. Ciofu, O., Mandsberg, L. F., Bjarnsholt, T., Wassermann, T. & Høiby, N. (2010). Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156, 1108–1119
16. Ciofu, O., Hansen, C. R. & Høiby, N. (2013). Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med 19, 251–258
17. Craig, A., Mai, J., Cai, S. & Jeyaseelan, S. (2009). Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immun 77, 568–575
18. D’Argenio, D. A., Wu, M., Hoffman, L. R., Kulasekara, H. D., Déziel, E., Smith, E. E., Nguyen, H., Ernst, R. K., Larson Freeman, T. J. & other authors (2007). Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64, 512–533
19. Damkiær, S., Yang, L., Molin, S. & Jelsbak, L. (2013). Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts. Proc Natl Acad Sci USA 110, 7766–7771
20. Darch, S. E., McNally, A., Harrison, F., Corander, J., Barr, H. L., Paszkiewicz, K., Holden, S., Fogarty, A., Crusz, S. A. & Diggle, S. P. (2015). Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Sci Rep 5, 7649
21. Döring, G., Flume, P., Heijerman, H. & Elborn, J. S. (2012). Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros 11, 461–479
22. Downey, D. G., Bell, S. C. & Elborn, J. S. (2009). Neutrophils in cystic fibrosis. Thorax 64, 81–88
23. Feliziani, S., Marvig, R. L., Luján, A. M., Moyano, A. J., Di Rienzo, J. A., Krogh Johansen, H., Molin, S. & Smania, A. M. (2014). Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet 10, e1004651
24. Folkesson, A., Jelsbak, L., Yang, L., Johansen, H. K., Ciofu, O., Høiby, N. & Molin, S. (2012). Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol 10, 841–851
25. Fothergill, J. L., Neill, D. R., Loman, N., Winstanley, C. & Kadioglu, A. (2014). Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs. Nat Commun 5, 4780
26. Frederiksen, B., Koch, C. & Høiby, N. (1997). Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23, 330–335
27. Garred, P., Pressler, T., Madsen, H. O., Frederiksen, B., Svejgaard, A., Høiby, N., Schwartz, M. & Koch, C. (1999). Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104, 431–437
28. Hansen, C. R., Pressler, T. & Høiby, N. (2008). Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 7, 523–530
29. Hansen, S. K., Rau, M. H., Johansen, H. K., Ciofu, O., Jelsbak, L., Yang, L., Folkesson, A., Jarmer, H. O., Aanæs, K. & other authors (2012). Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 6, 31–45
30. Häussler, S. (2004). Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. Environ Microbiol 6, 546–551
31. Hoboth, C., Hoffmann, R., Eichner, A., Henke, C., Schmoldt, S., Imhof, A., Heesemann, J. & Hogardt, M. (2009). Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 200, 118–130
32. Hoffman, L. R., Richardson, A. R., Houston, L. S., Kulasekara, H. D., Martens-Habbena, W., Klausen, M., Burns, J. L., Stahl, D. A., Hassett, D. J. & other authors (2010). Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6, e1000712
33. Hoffmann, N., Rasmussen, T. B., Jensen, P. Ø., Stub, C., Hentzer, M., Molin, S., Ciofu, O., Givskov, M., Johansen, H. K. & Høiby, N. (2005). Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun 73, 2504–2514
34. Hogardt, M. & Heesemann, J. (2010). Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol 300, 557–562
35. Høiby, N. (1974). Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B Microbiol Immunol 82, 541–550
36. Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S. & Ciofu, O. (2010a). Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35, 322–332
37. Høiby, N., Ciofu, O. & Bjarnsholt, T. (2010b). Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5, 1663–1674
38. Holloway, B. W. (1955). Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13, 572–581
39. Jelsbak, L., Johansen, H. K., Frost, A. L., Thøgersen, R., Thomsen, L. E., Ciofu, O., Yang, L., Haagensen, J. A. J., Høiby, N. & Molin, S. (2007). Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75, 2214–2224
40. Johansen, H. K., Nørregaard, L., Gøtzsche, P. C., Pressler, T., Koch, C. & Høiby, N. (2004). Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?—A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 37, 427–432
41. Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T. & Høiby, N. (2008). Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 7, 391–397
42. Johansen, H. K., Aanaes, K., Pressler, T., Nielsen, K. G., Fisker, J., Skov, M., Høiby, N. & von Buchwald, C. (2012). Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros 11, 525–531
43. Klausen, M., Heydorn, A., Ragas, P., Lambertsen, L., Aaes- Jørgensen, A., Molin, S. & Tolker-Nielsen, T. (2003). Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48, 1511–1524
44. Knudsen, P. K., Olesen, H. V., Høiby, N., Johannesson, M., Karpati, F., Laerum, B. N., Meyer, P., Pressler, T., Lindblad, A. & Scandinavian CF Study Consortium (SCFSC) (2009). Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros 8, 135–142
45. Koch, C. & Høiby, N. (1993). Pathogenesis of cystic fibrosis. Lancet 341, 1065–1069
46. Kolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., Ciofu, O., Mandsberg, L., Kharazmi, A. & other authors (2010). Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65, 57–62
47. Lindberg, R. B. & Latta, R. L. (1974). Phage typing of Pseudomonas aeruginosa: clinical and epidemiologic considerations. J Infect Dis 130, S33–S42
48. Maharjan, R. P., Seeto, S. & Ferenci, T. (2007). Divergence and redundancy of transport and metabolic rate-yield strategies in a single Escherichia coli population. J Bacteriol 189, 2350–2358
49. Malone, J. G., Jaeger, T., Spangler, C., Ritz, D., Spang, A., Arrieumerlou, C., Kaever, V., Landmann, R. & Jenal, U. (2010). YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa. PLoS Pathog 6, e1000804
50. Markussen, T., Marvig, R. L., Gόmez-Lozano, M., Aanæs, K., Burleigh, A. E., Høiby, N., Johansen, H. K., Molin, S. & Jelsbak, L. (2014). Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. MBio 5, e01592–e01e14
51. Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. (2015). Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet 47, 57–64
52. Mathee, K., Ciofu, O., Sternberg, C., Lindum, P. W., Campbell, J. I., Jensen, P., Johnsen, A. H., Givskov, M., Ohman, D. E. & other authors (1999). Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145, 1349–1357
53. Moeller, W., Schuschnig, U., Meyer, G., Hüussinger, K., Keller, M., Junge-Hülsing, B. & Mentzel, H. (2009). Ventilation and aerosolized drug delivery to the paranasal sinuses using pulsating airflow - a preliminary study. Rhinology 47, 405–412
54. Mowat, E., Paterson, S., Fothergill, J. L., Wright, E. A., Ledson, M. J., Walshaw, M. J., Brockhurst, M. A. & Winstanley, C. (2011). Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med 183, 1674–1679
55. Nishijyo, T., Haas, D. & Itoh, Y. (2001). The CbrA-CbrB twocomponent regulatory system controls the utilization of multiple carbon and nitrogen sources in Pseudomonas aeruginosa. Mol Microbiol 40, 917–931
56. Oberhardt, M. A., Puchałka, J., Fryer, K. E., Martins dos Santos, V. A. P. & Papin, J. A. (2008). Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1 J Bacteriol 190, 2790–2803
57. Palmer, K. L., Mashburn, L. M., Singh, P. K. & Whiteley, M. (2005). Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187, 5267–5277
58. Palmer, K. L., Aye, L. M. & Whiteley, M. (2007). Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189, 8079–8087
59. Palmer, G. C., Palmer, K. L., Jorth, P. A. & Whiteley, M. (2010). Characterization of the Pseudomonas aeruginosa transcriptional response to phenylalanine and tyrosine. J Bacteriol 192, 2722–2728
60. Pedersen, S. S., Møller, H., Espersen, F., Sørensen, C. H., Jensen, T. & Høiby, N. (1992). Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis. APMIS 100, 326–334
61. Pressler, T., Frederiksen, B., Skov, M., Garred, P., Koch, C. & Høiby, N. (2006). Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection – a case control study. J Cyst Fibros 5, 9–15
62. Pressler, T., Karpati, F., Granström, M., Knudsen, P. K., Lindblad, A., Hjelte, L., Olesen, H. V., Meyer, P., Høiby, N. & Scandinavian CF Study Consortium (2009). Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 8, 37–42
63. Rainey, P. B. & Travisano, M. (1998). Adaptive radiation in a heterogeneous environment. Nature 394, 69–72
64. Rasmussen, T. B., Skindersoe, M. E., Bjarnsholt, T., Phipps, R. K., Christensen, K. B., Jensen, P. O., Andersen, J. B., Koch, B., Larsen, T. O. & other authors (2005). Identity and effects of quorumsensing inhibitors produced by Penicillium species. Microbiology 151, 1325–1340
65. Rojo, F. (2010). Carbon catabolite repression in Pseudomonas: optimizing metabolic versatility and interactions with the environment. FEMS Microbiol Rev 34, 658–684
66. Rudkjøbing, V. B., Thomsen, T. R., Alhede, M., Kragh, K. N., Nielsen, P. H., Johansen, U. R., Givskov, M., Høiby, N. & Bjarnsholt, T. (2012). The micro-organisms in chronically infected end-stage and non-endstage cystic fibrosis patients. FEMS Immunol Med Microbiol 65, 236–244
67. Schobert, M. & Jahn, D. (2010). Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int J Med Microbiol 300, 549–556
68. Stoltz, D. A., Meyerholz, D. K. & Welsh, M. J. (2015). Origins of cystic fibrosis lung disease. N Engl J Med 372, 351–362
69. Taylor, R. F., Hodson, M. E. & Pitt, T. L. (1993). Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax 48, 1002–1005
70. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233–2239
71. Thomas, S. R., Ray, A., Hodson, M. E. & Pitt, T. L. (2000). Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55, 795–797
72. Totten, P. A., Lara, J. C. & Lory, S. (1990). The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene. J Bacteriol 172, 389–396
73. Tramper-Stranders, G. A., van der Ent, C. K., Molin, S., Yang, L., Hansen, S. K., Rau, M. H., Ciofu, O., Johansen, H. K. & Wolfs, T. F. W. (2012). Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates. Clin Microbiol Infect 18, 567–574
74. Valentini, M., Storelli, N. & Lapouge, K. (2011). Identification of C4- dicarboxylate transport systems in Pseudomonas aeruginosa. PAO1J Bacteriol 193, 4307–4316
75. Wahba, A. H. & Darrell, J. H. (1965). The identification of atypical strains of Pseudomonas aeruginosa. J Gen Microbiol 38, 329–342
76. Workentine, M. L., Sibley, C. D., Glezerson, B., Purighalla, S., Norgaard-Gron, J. C., Parkins, M. D., Rabin, H. R. & Surette, M. G. (2013). Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One 8, e60225
77. Yang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Høiby, N. & Molin, S. (2008). In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 190, 2767–2776
78. Yang, L., Jelsbak, L., Marvig, R. L., Damkiær, S., Workman, C. T., Rau, M. H., Hansen, S. K., Folkesson, A., Johansen, H. K. & other authors (2011). Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 108, 7481–7486.